Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain
Authors:
- Rafael BenitoRBRafael Benito
- Jose Manuel RamosJose Manuel Ramos
- Vicente SorianoVSVicente Soriano
- The HTLV Spanish Study GroupTGThe HTLV Spanish Study Group
- C RodríguezCRC Rodríguez
- M VeraMVM Vera
Open Access
- 16 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (2) , ofz036
Abstract
Background: Although only 8%–10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late diagnoses.Methods: A nationwide HTLV-1 register was created in Spain in 1989. A total of 351 infected persons had been reported by the end of 2017. We examined all new HTLV-1 diagnoses during the last decade and compared their clinical presentation.Results: A total of 247 individuals with HTLV-1 infection had been reported in Spain since year 2008. The incidence has remained stable with 20–25 new diagnoses yearly. Women represented 62%. Only 12% were native Spaniards, most of whom were foreigners from Latin America (72.5%). Up to 57 (23%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (n = 24; 42.1%), T-cell lymphoma (n = 19; 33.3%), or Strongyloides stercoralis infestation (n = 8; 14%). Human T-cell leukemia virus type 1 diagnosis had been made either at blood banks (n = 109; 44%) or at clinics (n = 138; 56%). It is interesting to note that Spaniards and especially Africans were overrepresented among patients presenting with HTLV-1-associated illnesses, suggesting that misdiagnosis and late presentation are more frequent in these populations compared to Latin Americans.Conclusions: Given that 23% of new HTLV-1 diagnoses in Spain are symptomatic, underdiagnosis must be common. Although screening in blood banks mostly identifies asymptomatic Latin American carriers, a disproportionately high number of Spaniards and Africans are unveiled too late, that is, they already suffer from classic HTLV-1 illnesses.Keywords
This publication has 21 references indexed in Scilit:
- Reducing the global burden of HTLV-1 infection: An agenda for research and actionAntiviral Research, 2017
- Screening transplant donors for HTLV-1 and -2Blood, 2016
- Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child TransmissionViruses, 2016
- Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safetyTransfusion Clinique et Biologique, 2016
- Inflammatory manifestations of HTLV-1 and their therapeutic optionsExpert Review of Clinical Immunology, 2014
- Molecular Epidemiology and Clinical Features of Human T Cell Lymphotropic Virus Type 1 Infection in SpainAIDS Research and Human Retroviruses, 2014
- Epidemiological Aspects and World Distribution of HTLV-1 InfectionFrontiers in Microbiology, 2012
- HTLV infection among foreign pregnant women living in SpainJournal of Clinical Virology, 2011
- Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus Type I from a single donorTransplantation, 2003
- Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemiaNature, 1981